OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

BAVARIAN NOR NAM. DK 10/  DK0015998017  /

Stuttgart
9/26/2024  5:35:04 PM Chg. -0.500 Volume Bid10:00:02 PM Ask10:00:02 PM Market Capitalization Dividend Y. P/E Ratio
31.370EUR -1.57% 555
Turnover: 17,573.700		 -Bid Size: - -Ask Size: - 24.78 bill.EUR - -
TeleTrader 8/22 Mpox vaccine maker, Bavarian Nordic, jumps 13% after earnings
GlobeNewswire 8/16 Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents
GlobeNewswire 8/13 Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
GlobeNewswire 8/8 Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vac...
GlobeNewswire 6/26 Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to...
GlobeNewswire 6/17 Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
GlobeNewswire 5/31 Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Sm...
GlobeNewswire 4/29 Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire 4/2 Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire 2/23 Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
TeleTrader 8/19/2022 EU makes monkeypox vaccine more available
TeleTrader 8/18/2022 WH announces new strategies against monkeypox
TeleTrader 7/30/2022 Spain confirms second monkeypox death
TeleTrader 7/29/2022 Spain confirms Europe's first monkeypox death
TeleTrader 7/25/2022 Monkeypox vaccine approved by EU
TeleTrader 7/22/2022 EMA gives preliminary approval to monkeypox jab
GlobeNewswire 3/21/2022 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire 2/28/2022 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire 2/14/2022 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire 12/6/2021 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire 12/5/2021 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire 9/1/2021 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire 8/23/2021 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire 8/23/2021 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire 8/9/2021 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine